For patients who have been on opioid therapy for months or years, stopping or reducing the dose is rarely as simple as writing a new prescription. Clinicians who care for people with chronic pain increasingly need well-defined opioid tapering strategies that protect patients from both the risks of continued high-dose therapy and the risks of withdrawal, undertreated pain, or abrupt discontinuation. This article offers an educational overview of how physicians and advanced practice providers (APPs) can think through a taper, drawing on guidance from the Centers for Disease Control and Prevention (CDC), the U.S. Department of Health and Human Services (HHS), and the U.S. Food and Drug Administration (FDA). It is not a substitute for individualized clinical judgment, and it intentionally avoids specific dosing recommendations, which should always be determined by the treating clinician based on the patient in front of them.
Why Clinicians Are Rethinking Long-Term Opioid Therapy
Over the past decade, the evidence base around chronic opioid therapy has shifted substantially. Long-term use is associated with tolerance, hyperalgesia in some patients, endocrine effects, falls, and an elevated risk of opioid use disorder (OUD). At the same time, national data and clinical experience have made clear that rapid or poorly supported tapers can cause serious harm of their own, including uncontrolled pain, psychological distress, and in some cases patients seeking opioids from illicit sources. This is precisely why thoughtful opioid tapering strategies matter: the goal is never simply "getting a patient off opioids" as quickly as possible, but finding the safest, most functional long-term plan for that individual.
What the CDC Guideline Says About Tapering
The CDC Clinical Practice Guideline for Prescribing Opioids for Pain (2022) is explicit that discontinuing opioids after extended use "can be challenging for clinicians and patients" and that tapering carries clinically significant risks when done rapidly or without support. Importantly, the CDC guideline also cautions against the misapplication of earlier opioid guidance, noting that rigid, one-size-fits-all tapers or abrupt discontinuation without collaboration contributed to patient harm in the years after the 2016 recommendations were published. For clinicians building opioid tapering strategies into their practice, this is a reminder that guidelines are meant to support individualized decision-making, not to mandate automatic dose reductions for every patient on long-term therapy.
Core Principles of a Safe Taper
Across CDC, HHS, and FDA resources, several themes recur consistently, and they form a useful framework for any clinician developing opioid tapering strategies for their own patients:
- Individualize the plan. The appropriate pace of a taper depends on the duration of therapy, the dose, comorbid conditions, prior withdrawal experiences, and the patient's goals. There is no universal schedule that fits every patient.
- Go slow for long-term use. The HHS Guide for Clinicians on the Appropriate Dosage Reduction or Discontinuation of Long-Term Opioid Analgesics notes that patients on opioids for a long time generally tolerate slower, more gradual reductions better than rapid ones, and that the taper can be paused or slowed if a patient is struggling.
- Never stop abruptly in a physically dependent patient. The FDA has required labeling changes reminding prescribers "not to stop opioids suddenly in patients who may be physically dependent, as it can cause serious harm."
- Collaborate with the patient. Shared decision-making, clear communication about the reasons for a taper, and setting realistic expectations all improve the likelihood of success and reduce the risk of the patient feeling abandoned.
- Monitor throughout. Ongoing assessment for withdrawal symptoms, mood changes, worsening function, and signs of opioid use disorder should continue for the duration of the taper and beyond.
Building a Practical, Education-Based Framework
When developing opioid tapering strategies for a given patient, many experienced clinicians work through a similar sequence of questions rather than a fixed protocol. First, is a taper clinically indicated right now, or would stabilizing the current regimen and addressing other issues (sleep, mood, physical function) be more appropriate first? Second, what non-opioid and non-pharmacologic therapies can be introduced or optimized before or during the taper, such as physical therapy, cognitive behavioral therapy for pain, interventional procedures, or non-opioid medications? Third, how will withdrawal symptoms and breakthrough pain be monitored and addressed if they occur? Fourth, what is the plan if the taper needs to be paused, slowed, or reversed? None of these questions have a single correct answer; they are meant to structure a conversation between clinician and patient, not to replace clinical judgment with a checklist.
Multimodal, opioid-sparing approaches are a natural companion to any taper. Patients who have other tools available to manage pain, whether that is a nerve block, a structured exercise program, or a behavioral health referral, tend to tolerate dose reductions more comfortably than patients who are relying on opioids alone. Clinicians building opioid tapering strategies into a broader pain management plan often find that investing in these adjuncts early makes the taper itself far less disruptive later.
When to Involve a Pain Specialist
Primary care physicians and APPs manage a great deal of chronic pain, but certain situations warrant referral or co-management with a pain medicine specialist: high daily opioid doses, concurrent benzodiazepine use, a history of substance use disorder, significant mental health comorbidity, or a patient who has failed previous taper attempts. Interventional options, such as ultrasound-guided injections or regenerative approaches, may also allow a reduction in systemic opioid exposure for appropriate candidates. Recognizing the limits of one's own comfort level with a complex taper, and building a referral relationship for cases that fall outside routine opioid tapering strategies, is itself part of a responsible, patient-centered approach.
A Note on Scope
This article is intended for clinician education only. It does not provide, and should not be interpreted as providing, specific dosing, tapering schedules, or medication recommendations for any individual patient. Decisions about whether, when, and how to taper opioid therapy should always be made by the treating clinician in direct collaboration with the patient, informed by current guidelines and the patient's complete clinical picture.
Pain Management Course for APPs
Expanding Your Toolkit Beyond Pharmacology
For many prescribers, confidence in opioid tapering strategies grows alongside confidence in alternative, opioid-sparing techniques. Hands-on training in ultrasound-guided procedures, for example, gives clinicians another option to offer patients whose pain has been managed primarily with systemic medication. NRAP Academy maintains an ongoing calendar of live and virtual training opportunities for physicians, nurse practitioners, and physician assistants who want to build these skills.
View the Ultrasound Course Calendar
Beyond scheduled courses, structured ultrasound training programs can help clinicians develop the procedural confidence needed to offer injection-based, opioid-sparing options as part of a comprehensive pain management plan.
Nurse practitioners and physician assistants who want a more structured, certificate-based path to deepen their pain management knowledge, including topics relevant to safe prescribing and tapering, may also be interested in dedicated certificate programs.
See Nurse Certificate Programs
Finally, for clinicians who prefer to learn on the go, the PainExam Podcast regularly features conversations with pain medicine experts on topics including opioid stewardship, multimodal analgesia, and evolving best practices for chronic pain management.
Listen to the PainExam Podcast
Key Takeaways
Safe, effective opioid tapering strategies are individualized, gradual, collaborative, and supported by non-opioid and non-pharmacologic therapies whenever possible. They are grounded in guidance from the CDC, HHS, and FDA, all of which emphasize that abrupt discontinuation can cause serious harm and that rigid, non-individualized tapers are not the standard of care. Physicians and APPs who build a consistent, principle-based approach to tapering, and who know when to involve a pain specialist, are better equipped to help patients reduce opioid exposure safely while maintaining function and trust in the care relationship.
Clinicians who are looking for Pain Management Board Prep or CME training in regional anesthesia, ultrasound-guided interventional pain, regenerative pain medicine, or ultrasound-guided IV placement should go to NRAPPain.org. Shadowing, online, private, and group training are available. Email Info@NRAPpain.org for details.